<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurol. Sci</journal-id>
<journal-title-group>
<journal-title>Neurological Sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">1590-1874</issn>
<issn pub-type="epub">1590-3478</issn>
<publisher>
<publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31267306</article-id>
<article-id pub-id-type="pmc">6817747</article-id>
<article-id pub-id-type="publisher-id">3998</article-id>
<article-id pub-id-type="doi">10.1007/s10072-019-03998-x</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Basal ganglia calcifications (Fahr’s syndrome): related conditions and clinical features</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Donzuso</surname>
<given-names>Giulia</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mostile</surname>
<given-names>Giovanni</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nicoletti</surname>
<given-names>Alessandra</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0393-4736</contrib-id>
<name>
<surname>Zappia</surname>
<given-names>Mario</given-names>
</name>
<address>
<phone>+39 0953782783</phone>
<email>m.zappia@unict.it</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.8158.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 1969</institution-id><institution>Department “GF Ingrassia”, Section Neuroscience, </institution><institution>University of Catania, </institution></institution-wrap>Via Santa Sofia 78, 95123 Catania, Italy </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>2</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>2</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<volume>40</volume>
<issue>11</issue>
<fpage>2251</fpage>
<lpage>2263</lpage>
<history>
<date date-type="received">
<day>8</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>6</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Basal ganglia calcifications could be incidental findings up to 20% of asymptomatic patients undergoing CT or MRI scan. The presence of neuropsychiatric symptoms associated with bilateral basal ganglia calcifications (which could occur in other peculiar brain structures, such as dentate nuclei) identifies a clinical picture defined as Fahr’s Disease. This denomination mainly refers to idiopathic forms in which no metabolic or other underlying causes are identified. Recently, mutations in four different genes (SLC20A2, PDGFRB, PDGFB, and XPR1) were identified, together with novel mutations in the Myogenic Regulating Glycosylase gene, causing the occurrence of movement disorders, cognitive decline, and psychiatric symptoms. On the other hand, secondary forms, also identified as Fahr’s syndrome, have been associated with different conditions: endocrine abnormalities of PTH, such as hypoparathyroidism, other genetically determined conditions, brain infections, or toxic exposure. The underlying pathophysiology seems to be related to an abnormal calcium/phosphorus homeostasis and transportation and alteration of the blood-brain barrier.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Fahr’s syndrome</kwd>
<kwd>Brain calcinosis</kwd>
<kwd>Basal ganglia</kwd>
<kwd>Hypoparathyroidism</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Fondazione Società Italiana di Neurologia 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par2">Basal ganglia calcifications are associated with a variety of neurological and metabolic disorders, and calcifications could be also frequent incidental findings on neuroimaging of asymptomatic individuals [<xref ref-type="bibr" rid="CR1">1</xref>]. Indeed, a certain degree of calcification of basal ganglia can be considered “physiological” with aging, over 50 years, and it could be an incidental finding in 15–20% of asymptomatic patients undergoing computed tomography (CT) scan [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR4">4</xref>].</p>
<p id="Par3">Even if this condition is traditionally known as Fahr’s disease or Fahr’s syndrome, Theodore Fahr was not the first to describe brain calcifications nor contribute significantly to the understanding of this disorder. He reported a case of an 81-year-old patient with long history of dementia and post-mortem evidence of calcifications in white matter, basal ganglia, and small cerebral arteries [<xref ref-type="bibr" rid="CR5">5</xref>], probably due to calcium-phosphorus abnormalities. Before him, in 1850, Delacour first described the presence of vascular calcifications of basal ganglia in a 56-year-old man who clinically had stiffness and weakness of lower extremities with tremor [<xref ref-type="bibr" rid="CR6">6</xref>]. Then, in 1855, Bamberger described the histopathological entity of calcifications in the thinner cerebral vessels in a woman who had mental retardation and seizures [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
<p id="Par4">Over the years, a variety of names have been associated with this condition; in 1974, the term “idiopathic basal ganglia calcification” (IBGC) was used for the first time [<xref ref-type="bibr" rid="CR8">8</xref>], reporting two cases of familial idiopathic basal ganglia calcifications exhibiting features of “dystonia musculorum deformans” and used for brain calcification of unknown origin. Then, as these calcifications tend to show a predilection for the dentate nuclei and basal ganglia, a descriptive term “bilateral striopallidodentate calcinosis (BSPDC)” has been suggested [<xref ref-type="bibr" rid="CR9">9</xref>]. In 2013, the term “primary familial brain calcification” (PFBC) has been introduced referring to a genetically confirmed neurodegenerative disorder with calcium deposits in the basal ganglia and other brain regions, in absence of a secondary cause [<xref ref-type="bibr" rid="CR10">10</xref>]. More than 100 kindreds and sporadic cases have been reported [<xref ref-type="bibr" rid="CR10">10</xref>], and the estimation of the minimal prevalence of PFBC from population genomic data analysis ranged from 4.5/10000 to 3.3/1000, using different level of evidence for pathogenicity [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
<p id="Par5">Very recently, the term “primary bilateral brain calcification” has been suggested for both inherited and sporadic cases, facilitating differentiation between primary and secondary forms, and encompassing the different anatomical distribution that can be found [<xref ref-type="bibr" rid="CR12">12</xref>]. However, considering the relative novelty of this new suggested nomenclature, in this review, we decided to maintain PFBC as the main term referring to both inherited and sporadic forms.</p>
<p id="Par6">On the other hand, the term “syndrome” has been suggested when a secondary, and potentially treatable, cause is found [<xref ref-type="bibr" rid="CR13">13</xref>], and it has been associated with different conditions, especially endocrine diseases. In these conditions, metabolic dysfunctions lead to an abnormal calcium/phosphorus ratio with precipitation of colloids in cerebral vessels and composition of calcified deposits [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
<p id="Par7">In this review, we aim to clearly describe conditions characterized by basal ganglia calcification considering primary and secondary forms. A radiological description, an approach to diagnosis, and management are also discussed.</p>
</sec>
<sec id="Sec2">
<title>Search strategy and selection criteria</title>
<p id="Par8">References for this review were identified by searches of PubMed up to June 1, 2019, and references from relevant articles. The search terms <italic>BSPDC</italic>, <italic>PFBC</italic>, <italic>IBGC</italic>, <italic>brain calcification</italic>, <italic>Fahr disease</italic>, OR <italic>basal ganglia calcification</italic> were used. We carried out a second search that included all publications up to June 1, 2019, using search terms: <italic>hypoparathyroidism</italic>, <italic>parathyroid</italic>, <italic>thyroid surgery</italic> AND <italic>brain calcifications</italic> OR <italic>basal ganglia calcifications</italic>. There were no language restrictions and the the final reference list was generated on the basis of relevance to the topics covered in this review</p>
</sec>
<sec id="Sec3">
<title>Neuroimaging features</title>
<p id="Par9">Since the advent of the head CT scan, the number of case reports of intracranial calcifications increased over time. CT and magnetic resonance imaging (MRI) are widely used in clinical practice to identify and quantify mineral deposition [<xref ref-type="bibr" rid="CR15">15</xref>]. Calcified areas could be easily identified as hyperdense lesions on CT that is considered decisive for accurate diagnosis, while, studies differ in their reporting of calcium on routine MRI sequences [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Calcium is a diamagnetic substance that may appear bright at T1-weighted imaging [<xref ref-type="bibr" rid="CR17">17</xref>], but, at higher concentrations, the intensity of the signal in calcium at T1-weighted imaging diminishes [<xref ref-type="bibr" rid="CR18">18</xref>]. On the other hand, calcified lesions could appear hypointense/hyperintense in T2-weighted MR images, because of the presence of other minerals in the same areas and the difference in the composition of calcium deposits, such as zinc, manganese, iron, and magnesium [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Moreover, it has been suggested that hyperintense T2-weighted lesions may be due to a progressive inflammatory process involving brain structures, which could be cause and/or consequence of calcification itself [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR21">21</xref>] (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Recently, some authors suggested that susceptibility-weighted images (SWI), a fully velocity compensated 3D gradient-echo (GE) MR sequence with high sensitivity for blood products and iron, could definitively recognize calcifications, appearing hypointense, with higher sensitivity compared with other MRI sequences [<xref ref-type="bibr" rid="CR15">15</xref>].<fig id="Fig1"><label>Fig 1</label><caption><p>Brain MRI showing T1-w hyperintensity in basal ganglia (<bold>a</bold>) and severe T2*-GRE hypointensities in the same regions (<bold>b</bold>). Brain CT scan showing diffuse symmetric calcifications involving basal ganglia (<bold>c</bold>), and dentate nucleus (<bold>d</bold>). GRE gradient recalled echo, FLAIR fluid-attenuated inversion recovery</p></caption><graphic id="MO1" xlink:href="10072_2019_3998_Fig1_HTML"></graphic></fig></p>
<p id="Par10">Regarding lesions’ distribution pattern and qualitative aspects, calcifications are typically bilateral and symmetrical, most frequently located in the basal ganglia, but also in dentate nuclei, thalamus, brain stem, centrum semiovale, and subcortical white matter [<xref ref-type="bibr" rid="CR15">15</xref>]. Pathological lesions can be easily distinguished from age-related physiological calcifications of basal ganglia for their features: the latter are often small and faint, symmetrical and confined into the globus pallidus, whereas the first are more diffuse and extensive, involving also the putamen and the dentate nucleus, and usually show a coarse conglomerate pattern [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
<p id="Par11">Cerebral scintigraphies can detect functional/metabolic abnormalities and evaluate the integrity of the nigrostriatal and striato-cortical pathways. Brain perfusion, positron emission tomography/computed tomography (PET/CT), and dopamine transporter single-photon emission computed tomography (DaT-SPECT) data showed conflicting results [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR23">23</xref>–<xref ref-type="bibr" rid="CR28">28</xref>]. In a case of Fahr’s disease with frontal lobe-type dementia and hyperkinetic-hypotonic syndrome, characterized by intermittent mild dystonic movements of hands, facial grimacing, and reduced muscular tonus of the extremities, <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) PET/CT showed reduced glucose uptake not only in putamen and globus pallidus but also in temporal and parietal cortices, bilaterally [<xref ref-type="bibr" rid="CR23">23</xref>]. The authors suggested that the reduced glucose cortical uptake could be secondary to the impaired circuits’ function involving the basal ganglia [<xref ref-type="bibr" rid="CR23">23</xref>]. These findings were consistently confirmed by subsequent studies [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>] showing a perfusion deficit in basal ganglia regions detected by Tc-99m HMPAO brain perfusion [<xref ref-type="bibr" rid="CR28">28</xref>] and by <sup>18</sup>F-FDG PET [<xref ref-type="bibr" rid="CR29">29</xref>] suggesting that calcifications could play a critical role in the pathogenesis of neuronal degeneration. Le Ber and coll [<xref ref-type="bibr" rid="CR25">25</xref>] showed a significantly reduced <sup>18</sup>F-FDG uptake in striatal and cortical areas, including the precuneus, posterior cingulate, and superior temporal gyri, in patients with familial calcifications and cognitive and psychiatric symptoms.</p>
<p id="Par12">Similarly, the evaluation of the dopaminergic system and striatal uptake showed heterogeneous results. In two patients with PFBC, <sup>18</sup>F-fluoro-L-dopa uptake did not reveal any difference between patients and control subjects suggesting no evidence of dysfunction of the nigrostriatal dopaminergic pathway [<xref ref-type="bibr" rid="CR9">9</xref>]. Saito and coll [<xref ref-type="bibr" rid="CR26">26</xref>] used PET with [<sup>11</sup>C]-labeled 2<italic>β</italic>-carbomethoxy-3<italic>β</italic>-(4-flurophenyl)-tropane ([<sup>11</sup>C]CFT), a ligand for the striatal pre-synaptic DA transporter, and [<sup>11</sup>C]-labeled raclopride ([<sup>11</sup>C]RAC), which binds DA D2 receptors and reflects postsynaptic DA function, in a case of PFBC with psychiatric symptoms and drug-induced parkinsonism. PET scanning showed a severe decline in pre- and postsynaptic dopaminergic function in bilateral striatum, suggesting the disruption of cortico-subcortical circuits [<xref ref-type="bibr" rid="CR26">26</xref>]. Regarding DaT-SPECT with <sup>123</sup>I-ioflupane and a possible nigrostriatal involvement, there were also conflicting results [<xref ref-type="bibr" rid="CR27">27</xref>–<xref ref-type="bibr" rid="CR29">29</xref>]. Two studies [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>] found a reduction in DaT binding in striatum regions in patients with basal ganglia calcifications presenting with parkinsonism and cognitive impairment; on the other hand, it has been reported normal striatal uptake, despite the presence of diffuse calcifications of basal ganglia documented bilaterally by a CT scan in patients with psychiatric symptoms and tremor [<xref ref-type="bibr" rid="CR29">29</xref>] and with parkinsonism and cognitive impairment [<xref ref-type="bibr" rid="CR30">30</xref>].</p>
<p id="Par13">These results suggest that the different patterns of brain perfusion and dopaminergic function could be related to brain plasticity and neuronal adaptation to calcifications, leading to different structural and functional neuroimaging features.</p>
</sec>
<sec id="Sec4">
<title>Neuropathology</title>
<p id="Par14">Recent neuropathological data suggest that PFBC is a disease of the cerebral microvessels, involving first vascular smooth muscles cells and pericytes. Moreover, very recently, hypodermal microvessel calcifications within and around the pericytes in the basal lamina in skin biopsies from patients with a genetic form of familial calcifications have been shown [<xref ref-type="bibr" rid="CR31">31</xref>]. Histopathological studies showed that calcium is the major element present and it accounts for the radiological appearance of the disease, together with the involvement of several minerals like iron, magnesium, aluminum, and zinc [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Macropathologic examination showed gray discoloration and gritty consistency of the posterior periventricular region, globus pallidus, putamen, and anterior thalamus and mild atrophy of the caudate nucleus, as well as in the cerebral cortex [<xref ref-type="bibr" rid="CR33">33</xref>]. Reactive astrocytes and microglia accumulated around the calcified deposits, indicating a mild ongoing inflammatory process [<xref ref-type="bibr" rid="CR34">34</xref>]. Calcifications were also observed in the tunica media of medium- and small-caliber arteries, arterioles, and capillaries leading to the obstruction of the lumen [<xref ref-type="bibr" rid="CR35">35</xref>]. In addition, analysis of the blood-brain barrier showed that extravasation and perivascular deposition of fibrinogen was focally associated with areas of calcification [<xref ref-type="bibr" rid="CR34">34</xref>]. Similar findings had been shown also in patients with brain calcifications due to pseudopseudohypoparathyroidism [<xref ref-type="bibr" rid="CR36">36</xref>] and longstanding hypoparathyroidism [<xref ref-type="bibr" rid="CR37">37</xref>], suggesting a common neuropathological pathway involving pericytes and endothelial environment both in primary and secondary forms.</p>
</sec>
<sec id="Sec5">
<title>Classification</title>
<p id="Par15">In 2005, Manyam proposed a classification based on the anatomical sites where calcification occurred, identifying bilateral striopallidodentate calcinosis, striopallido (“basal ganglia”) calcinosis, and dentate (cerebellar) calcinosis [<xref ref-type="bibr" rid="CR1">1</xref>]. Otherwise, in order to identify possible biochemical abnormalities or reversible causes that result in deposition of calcium, a classification based on etiology has been proposed, i.e., primary/genetic forms of basal ganglia calcinosis, which includes autosomal dominant, familial and sporadic forms, and secondary forms associated with different diseases [<xref ref-type="bibr" rid="CR1">1</xref>] (Table <xref ref-type="table" rid="Tab1">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Etiological classification of basal ganglia calcifications</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="2">Primary forms</td></tr><tr><td>  Gene</td><td>Chromosome position</td></tr><tr><td>    SLC20A2</td><td>8p11.21</td></tr><tr><td>    PDGFRB</td><td>5q32</td></tr><tr><td>    PDGFB</td><td>22q13.1</td></tr><tr><td>    XPR1</td><td>1q25.3</td></tr><tr><td>    MYORG</td><td>9p13.3</td></tr><tr><td colspan="2">Secondary forms</td></tr><tr><td rowspan="5"></td><td>Calcium/phosphorus abnormalities</td></tr><tr><td>- Idiopathic or secondary hypoparathyroidism</td></tr><tr><td>Infections (brucellosis, AIDS, toxoplasmosis, TORCH complex)</td></tr><tr><td>Toxic exposure (lead, carbon monoxide)</td></tr><tr><td>Disimmunopathies (SLE)</td></tr><tr><td colspan="2">Other conditions</td></tr><tr><td rowspan="6"></td><td>Pseudohypoparathyroidism</td></tr><tr><td>Cockayne syndrome I and II</td></tr><tr><td>Aicardi-Goutières syndrome</td></tr><tr><td>Mitochondrial diseases (MELAS, MERRF)</td></tr><tr><td>Coat’s syndrome</td></tr><tr><td>Neuroferritinopathy, NBIA</td></tr></tbody></table><table-wrap-foot><p><italic>SLC20A2</italic>, solute carrier family 20 member 2; <italic>PDGFB</italic>, platelet-derived growth factor beta; <italic>PDGFRB</italic>, platelet-derived growth factor receptor beta; <italic>XPR1</italic>, Xenotropic and Polytropic Retrovirus Receptor 1; <italic>MYORG</italic>, Myogenic Regulating Glycosilase; <italic>MELAS</italic>, mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes; <italic>MERRF</italic>, myoclonic epilepsy with ragged red fibers; <italic>NBIA</italic>, neurodegeneration with brain iron accumulation; <italic>SLE</italic>, systemic lupus erythematosus</p></table-wrap-foot></table-wrap></p>
<sec id="Sec6">
<title>Primary forms</title>
<p id="Par16">Primary form refers to PFBC. PFBC manifests as autosomal dominant, familial, and sporadic forms; in these cases, there is the absence of metabolic or other secondary causes. Sporadic forms might be due either to de novo mutations or to a mutation transmitted by an undiagnosed, asymptomatic parent [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Genetic analyses of large families affected by autosomal dominant brain calcifications identified 2 loci named idiopathic basal ganglia calcification (IBGC) 1, located in chromosome 14q48 [<xref ref-type="bibr" rid="CR39">39</xref>] and IBGC 2, in chromosome 2q37 [<xref ref-type="bibr" rid="CR40">40</xref>]. In the following years, mutations in three other genes have been found to cause the disease: solute carrier family 20 member 2 (SLC20A2) within the IBGC 3 locus, platelet-derived growth factor receptor beta (PDGFRB), and platelet-derived growth factor subunit beta (PDGFB) subsequently designated as IBGC 4 and IBGC 5, respectively [<xref ref-type="bibr" rid="CR41">41</xref>]. Additionally, mutations in Xenotropic and Polytropic Retrovirus Receptor 1 (XPR1) were identified and designated as IBGC 6 [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Recently, sequencing analysis revealed a linkage between IBGC 1 and IBGC 3 [<xref ref-type="bibr" rid="CR44">44</xref>] and identified multiexonic SLC20A2 deletions in the IBGC2 kindred [<xref ref-type="bibr" rid="CR45">45</xref>], so that IBGC 1 and IBGC 2, identified as false loci, now all map to the SLC20A2 gene (IBGC 3). SLC20A2, located at 8p11.21, encodes the inorganic phosphate transporter PiT-2, a transmembrane protein associated with phosphate homeostasis in various tissues, including the brain, and its mutations result in a reduction of phosphate transport [<xref ref-type="bibr" rid="CR38">38</xref>]. Mutations in SLC20A2 gene are responsible for most cases identified so far and over 40 pathogenic variants have been reported in patients with PFBC [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Microarray analysis provided evidence that the neuroanatomical pattern of expression for SLC20A2 is highest in the regions most commonly affected in PFBC, showing that globus pallidus had the highest expression among basal ganglia, followed by thalamus and cerebellum [<xref ref-type="bibr" rid="CR48">48</xref>].</p>
<p id="Par17">PDGFRB (5q32) and PDGFB (22q13.1) are involved in pericytes recruitment, blood-brain barrier regulation, and angiogenesis [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. XPR1 (1q25.3) is a gene encoding a retroviral receptor with phosphate export function and involved in phosphate homeostasis [<xref ref-type="bibr" rid="CR42">42</xref>]. Very recently, mutations in the Myogenic Regulating Glycosylase (MYORG) gene were identified as a novel genetic cause for autosomal-recessive PFBC in Chinese patients [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. MYORG gene encodes a glycosyl hydrolase involved in myogenesis and expressed throughout the brain, particularly in the cerebellum, but its role in the pathogenesis of PFBC is yet unknown [<xref ref-type="bibr" rid="CR53">53</xref>].</p>
<p id="Par18">A systematic review from 2012 (when genes for PFBC were discovered) to November 2016 collected 137 cases, of which 34 were familial, and showed that SLC20A2 was the most common gene involved in 75 out of 137 cases (54.7%), followed by PDGFB (43 cases—31.4%) and PDGFRB (13 cases—9.5%). XPR1 gene mutations were present in 6 cases (4.3%) [<xref ref-type="bibr" rid="CR54">54</xref>]. Over the years, several case reports described mutation variants, with peculiar clinical presentation, in SLC20A2 [<xref ref-type="bibr" rid="CR55">55</xref>–<xref ref-type="bibr" rid="CR58">58</xref>], PDGFB [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>], PDGFRB [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>], and XPR1 [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>].</p>
<p id="Par19">The clinical phenotype encompasses neurologic and psychiatric features. Neuropsychiatric symptoms could be present in the form of schizophrenia like psychosis, depression, and irritability, and patients with extensive calcification seem to exhibit a higher frequency of psychiatric disorders than patients with limited involvement of brain structures [<xref ref-type="bibr" rid="CR10">10</xref>]. Neurologic disturbances are heterogeneous; movement disorders are more commonly described, but seizures, headache, and cerebellar symptoms may occur. Neuropsychiatric features are also variable and include cognitive impairment, mood disorders, psychotic symptoms, and obsessive-compulsive symptoms [<xref ref-type="bibr" rid="CR38">38</xref>]. Table <xref ref-type="table" rid="Tab2">2</xref> shows the types and frequencies of symptoms in patients with genetically proven PFBC observed in three recent studies including sporadic and familial cases [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. In particular, genotype-phenotype analysis showed parkinsonism seemed to be more common in SCL20A2, occurring up to 70% of patients, with the involvement of basal ganglia, thalamus, and dentate nucleus [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. Analysis of cases reported with PDGFB mutations had hyperkinetic movements up to 25% of cases, cerebellar symptoms and headache, but also psychiatric manifestations, with calcifications of basal ganglia and cerebellum, while PDGFRB abnormalities were associated with depression, cognitive impairment, and headache. XPR1 mutations showed cognitive dysfunction (66.7%) with hyperkinetic movements and dysarthria and cortical calcifications [<xref ref-type="bibr" rid="CR54">54</xref>]. Moreover, patients with an early onset presented most frequently with psychiatric or cognitive symptoms, while older patients exhibited mostly movement disorders [<xref ref-type="bibr" rid="CR67">67</xref>]. Considering only movement disorders, parkinsonism was found up to 85%, chorea in 19%, tremor in 8%, dystonia in 8–19%, athetosis in 5%, and orofacial dyskinesia in 3% of patients [<xref ref-type="bibr" rid="CR66">66</xref>–<xref ref-type="bibr" rid="CR68">68</xref>]. Furthermore, affected members of the same family with a novel SCL20A2 mutation presented with similar brain calcification distribution but different cognitive and behavioral signs [<xref ref-type="bibr" rid="CR69">69</xref>]. Later, Ramos and coll [<xref ref-type="bibr" rid="CR70">70</xref>], by screening the well-known PFBC genes in four cohorts from America and Europe, found known and novel mutations of SLC20A2, PDGFB, PDGFRB, and XPR1, confirming the higher prevalence of SLC20A2 as the major causative gene (up to 13%) and, consistent with previous series, the most frequent symptoms were parkinsonism (52.3% of symptomatic individuals), cognitive impairment (40.9%), and psychiatric signs (38.6%) [<xref ref-type="bibr" rid="CR70">70</xref>].<table-wrap id="Tab2"><label>Table 2</label><caption><p>Clinical features of patients with genetically confirmed primary familial brain calcification</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">No. of cases</th><th colspan="3">57 cases (22 families) [<xref ref-type="bibr" rid="CR51">51</xref>]</th><th colspan="3">167 cases (25 families) [<xref ref-type="bibr" rid="CR55">55</xref>]</th><th colspan="4">137 cases (34 families) [<xref ref-type="bibr" rid="CR47">47</xref>]</th></tr><tr><th>SLC20A2</th><th>PDGFB</th><th>PDGFRB</th><th>SLC20A2</th><th>PDGFB</th><th>PDGFRB</th><th>SLC20A2</th><th>PDGFB</th><th>PDGFRB</th><th>XPR1</th></tr><tr><th>24</th><th>19</th><th>14</th><th>119</th><th>32</th><th>16</th><th>75</th><th>43</th><th>13</th><th>6</th></tr></thead><tbody><tr><td>Symptomatic (% within the mutation)</td><td>17 (70.8)</td><td>11 (57.8)</td><td>5 (35.7)</td><td>71 (59.7)</td><td>23 (71.9)</td><td>7 (46.7)</td><td>57 (76)</td><td>32 (74.4)</td><td>6 (46.1)</td><td>6 (100)</td></tr><tr><td>Seizures<sup>a</sup></td><td>0 (0)</td><td>1 (9.9)</td><td>0 (0)</td><td>3 (2.5)</td><td>0 (0)</td><td>0 (0)</td><td>5 (8.7)</td><td>2 (6.2)</td><td>0 (0)</td><td>0 (0)</td></tr><tr><td>Cognitive impairment<sup>a</sup></td><td>11 (64.7)</td><td>6 (54.5)</td><td>2 (40)</td><td>18 (25.3)</td><td>5 (7)</td><td>0 (0)</td><td>6 (10.5)</td><td>6 (18.7)</td><td>1 (16.7)</td><td>4 (66.6)</td></tr><tr><td>Parkinsonism<sup>a</sup></td><td>12 (70.6)</td><td>3 (27.3)</td><td>2 (40)</td><td>16 (22.5)</td><td>3 (13)</td><td>2 (28.6)</td><td>16 (28)</td><td>3 (9.3)</td><td>1 (16.7)</td><td>3 8(0)</td></tr><tr><td>Tremor<sup>a</sup></td><td>6 (35.3)</td><td>2 (18.2)</td><td>1 (20)</td><td>NA</td><td>NA</td><td>NA</td><td>14 (24.5)</td><td>8 (25)</td><td>1 (16.7)</td><td>1 (16.7)</td></tr><tr><td>Dystonia<sup>a</sup></td><td>6 (35.3)</td><td>2 (18.2)</td><td>1 (20)</td><td>22 (30.9)</td><td>7 (30.4)</td><td>0 (0)</td><td>10 (17.5)</td><td>4 (12.5)</td><td>0 (0)</td><td>0 (0)</td></tr><tr><td>Ataxia/cerebellar symptoms<sup>a</sup></td><td>1 (5.9)</td><td>2 (18.2)</td><td>1 (20)</td><td>7 (9.8)</td><td>4 (17.4)</td><td>2 (28.6)</td><td>6 (10.5)</td><td>6 (18.7)</td><td>0 (0)</td><td>1 (16.7)</td></tr><tr><td>Chorea<sup>a</sup></td><td>1 (5.9)</td><td>1 (9.1)</td><td>1 (20)</td><td>NA</td><td>NA</td><td>NA</td><td>9 (15.7)</td><td>6 (18.7)</td><td>1 (16.7)</td><td>1 (16.7)</td></tr><tr><td>Dysarthria<sup>a</sup></td><td>5 (29.4)</td><td>3 (27.2)</td><td>1 (20)</td><td>NA</td><td>NA</td><td>NA</td><td>5 (8.7)</td><td>1 (3.1)</td><td>0 (0)</td><td>2 (33.3)</td></tr><tr><td>Headache<sup>b</sup></td><td>6 (25)</td><td>5 (26.3)</td><td>3 (21.4)</td><td>16 (13.4)</td><td>14 (43.8)</td><td>3 (20.0)</td><td>3 (4)</td><td>14 (32.5)</td><td>3 (23.1)</td><td>0 (0)</td></tr><tr><td>Psychiatric symptoms<sup>a</sup></td><td>13 (76.4)</td><td>8 (872.7)</td><td>4 (80)</td><td>19 (26.7)</td><td>5 (7)</td><td>0 (0)</td><td>9 (15.7)</td><td>13 (40)</td><td>3 (50)</td><td>2 (33.3)</td></tr></tbody></table><table-wrap-foot><p>Data shown as <italic>n</italic> (% within the mutation); <sup>a</sup>among symptomatic patients; <sup>b</sup>among all patients. <italic>NA</italic>, not available; <italic>SLC20A2</italic>, solute carrier family 20 member 2; <italic>PDGFB</italic>, platelet-derived growth factor beta; <italic>PDGFRB</italic>, platelet-derived growth factor receptor beta; <italic>XPR1</italic>, Xenotropic and Polytropic Retrovirus Receptor 1</p></table-wrap-foot></table-wrap></p>
<p id="Par20">Very recently, Guo and coll [<xref ref-type="bibr" rid="CR64">64</xref>] described the mutational spectrum of the first four discovered causative genes in a series of PFBC in Chinese patients, including 35 families and 191 sporadic individuals. They found different prevalence of mutations and symptoms than those of previous studies [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>], underlining the heterogeneity of genotype-phenotype correlation. SLC20A2 mutations were found in 14.2% of all patients, while mutations in the other three genes were very rare, accounting for 0.9% of all patients, respectively. Among symptomatic patients (44.8%), the most common symptoms were chronic headache (23.3%), movement disorders (20%), and vertigo (16.7%); moreover, total calcifications score was related to clinical symptoms and was higher in patients with SLC20A2 mutations [<xref ref-type="bibr" rid="CR64">64</xref>].</p>
<p id="Par21">Differently from the other identified mutations, MYORG mutation carriers showed a very homogenous clinical presentation [<xref ref-type="bibr" rid="CR71">71</xref>]. Dysarthria was present in 100% of symptomatic patients, together with the development of other features including akinetic-hypertonic syndrome (100%), cerebellar syndrome (66.6%), gait disorders, and pyramidal signs (86.6%). Moreover, they showed a distinct radiological pattern including cerebellar atrophy and severe extensive calcifications involving the pons [<xref ref-type="bibr" rid="CR71">71</xref>].</p>
<p id="Par22">This wide spectrum of clinical presentation, even in the same pedigree in which individuals shared the same causing mutation, could be due to the different pathogenicity caused by different types of mutations, penetrance and expressivity, and “resilience” brain ability of individuals [<xref ref-type="bibr" rid="CR72">72</xref>], and may depend on location of calcium deposits [<xref ref-type="bibr" rid="CR54">54</xref>] but no obvious association between the site of calcification on CT and the type of clinical sign was observed [<xref ref-type="bibr" rid="CR66">66</xref>]. Moreover, although Tadic and coll (2015) showed that penetrance of the imaging phenotype was 100%, interestingly, almost a quarter of cases included in the analysis were asymptomatic, suggesting reduced penetrance of the mutations and/or incomplete reporting and/or unrecognized clinical symptoms and signs in carriers of mutations [<xref ref-type="bibr" rid="CR66">66</xref>]. The spectrum of clinical symptoms of PFBC is further complicated by the presence of known mutations in a second gene that may contribute to or be entirely responsible for the disease manifestation [<xref ref-type="bibr" rid="CR73">73</xref>], such as SLC20A2 and the neighboring THAP1 gene in a large dystonia family [<xref ref-type="bibr" rid="CR74">74</xref>] or changes in the epilepsy-linked SCN2A gene in combination with SLC20A2 variants in PFBC patients with refractory seizures [<xref ref-type="bibr" rid="CR75">75</xref>].</p>
<p id="Par23">These data also support the evidence that genetic forms of brain calcification could be underestimated suggesting the importance of future studies in asymptomatic patients carrying genetic mutations.</p>
</sec>
<sec id="Sec7">
<title>Secondary forms</title>
<p id="Par24">Secondary forms of brain calcifications have been associated with different conditions. In these cases, the term “Fahr’s syndrome” has been proposed by some authors, to describe the heterogeneity of neuropsychiatric and neuroradiological features associated to the underlying causes [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. The clinical history, examination, and laboratory findings are crucial for differential diagnosis. It is possible to identify secondary forms associated with endocrine disorders, especially hypoparathyroidism, leading to calcium/phosphorus abnormalities or other secondary conditions, such as infectious or toxic agents, when a documented exposition has been shown.</p>
<sec id="Sec8">
<title>Calcium/phosphorus abnormalities in hypoparathyroidism</title>
<p id="Par25">Calcium/phosphorus (Ca/P) ratio abnormalities, particularly due to parathyroid hormone (PTH) disorders, appear to be the most common definable etiology for calcification of white matter and bilateral subcortical nuclei [<xref ref-type="bibr" rid="CR68">68</xref>]. The principal function of PTH is maintenance of calcium plasmatic levels, withdrawing the calcium from bone tissue, reabsorbing it from the glomerular filtrate, and indirectly increasing its intestinal absorption by stimulating active vitamin D (calcitriol) production [<xref ref-type="bibr" rid="CR76">76</xref>]. Additionally, the PTH promotes an increase in urinary excretion of phosphorus and bicarbonate [<xref ref-type="bibr" rid="CR77">77</xref>].</p>
<p id="Par26">The most common causes leading to calcium homeostasis disorder include idiopathic or secondary hypoparathyroidism. Idiopathic hypoparathyroidism is an uncommon condition with a prevalence of 37 per 100.000 [<xref ref-type="bibr" rid="CR78">78</xref>], characterized by the absence, fatty replacement, or atrophy of the parathyroid glands [<xref ref-type="bibr" rid="CR13">13</xref>]. In a study of 147 patients with idiopathic hypoparathyroidism, 107 patients (73.8%) showed basal ganglia calcifications on CT scan and its occurrence and progression were associated with low Ca/P ratio [<xref ref-type="bibr" rid="CR79">79</xref>]. On the other hand, long-term hyperphosphatemia could lead to down regulation of phosphate transporter in basal ganglia, thus determining colloid precipitation in cerebral blood vessels and brain calcification [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
<p id="Par27">Secondary hypoparathyroidism is a relatively frequent complication of total or subtotal thyroidectomy with an incidence ranging from 6.9 to 46% for transient hypoparathyroidism, and from 0.9 to 1.6% for permanent hypoparathyroidism [<xref ref-type="bibr" rid="CR76">76</xref>]. In an analysis of 170 consecutive patients undergoing primary total thyroidectomy, 41 patients (24.1%) developed transient hypoparathyroidism and 2 patients (1.2%) developed permanent hypoparathyroidism [<xref ref-type="bibr" rid="CR80">80</xref>]. Epidemiological studies estimate the incidence of hypoparathyroidism related to neck surgery in the USA, which is reported in 7–36% of surgeries, of which 38% are due to total thyroidectomy, 21% parathyroidectomy, 9% partial thyroidectomy, and 5% other neck surgeries [<xref ref-type="bibr" rid="CR78">78</xref>]. Consequently, the most common clinical scenario underlying basal ganglia and dentate nuclei calcifications is secondary hypoparathyroidism due to thyroid surgery with destruction or vascular compromise of parathyroid tissue, with an abnormal Ca/P ratio, leading to hyperphosphatemia and hypocalcaemia [<xref ref-type="bibr" rid="CR81">81</xref>]. Symptoms due to hypocalcaemia include paresthesia, cramps, spasm of carpal and pedal muscles, seizures, neuromuscular irritability, and ECG abnormalities such as prolonged QT interval and neurological signs [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR82">82</xref>–<xref ref-type="bibr" rid="CR92">92</xref>]. CT scan shows bilateral symmetrical calcifications involving basal ganglia, thalamus, corona radiata, and subcortical white matter and cerebellum [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR82">82</xref>–<xref ref-type="bibr" rid="CR92">92</xref>] and a variety of neurological signs and symptoms were described, such as seizures, loss of consciousness, falls, gait disturbances and postural instability, cognitive decline, parkinsonism, and rest tremor [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR82">82</xref>–<xref ref-type="bibr" rid="CR92">92</xref>]. Although calcifications of basal ganglia were present in all cases, clinical features were different and heterogenic suggesting that there is no clear correlation between brain areas involved and clinical signs.</p>
</sec>
<sec id="Sec9">
<title>Infections</title>
<p id="Par28">Brain infections, such as brucellosis, acquired immune deficiency syndrome (AIDS), toxoplasmosis, but also intrauterine and perinatal congenital infections (toxoplasmosis, rubella, cytomegalovirus, or herpes simplex virus—TORCH complex) could determine brain calcifications [<xref ref-type="bibr" rid="CR10">10</xref>]. Brucellosis is a zoonosis that affects animals as the primary host (e.g., sheep, goats) and humans as the secondary host. Neurobrucellosis occurs in 5–10% of cases of brucellosis and affects the central or peripheral nervous system. This may lead to a variety of clinical manifestations and imaging abnormalities that mimic other neurologic diseases [<xref ref-type="bibr" rid="CR93">93</xref>]. Brain calcifications are rare, involving basal ganglia, dentate nucleus, and white matter, and the detection in individuals residing in endemic areas should raise the possibility of brucellar infection involving the central nervous system [<xref ref-type="bibr" rid="CR94">94</xref>].</p>
<p id="Par29">Immunodeficiency caused by human immunodeficiency virus type 1 (HIV) determines a broad spectrum of clinical and pathological features. Pathologically, the terminal HIV-infected patient usually shows severe depletion of lymphoid tissue and opportunistic infections. Calcification is one of the most common pathological findings and involves blood vessels of multiple organs, including the brain [<xref ref-type="bibr" rid="CR95">95</xref>]. Up to 33% of HIV-infected children show bilateral and symmetrical basal ganglia calcifications, involving putamen and globus pallidus and are usually not seen before 10 months of age [<xref ref-type="bibr" rid="CR96">96</xref>]. In a retrospective autopsy study, 85 HIV-infected adult brains were examined and calcifications were observed in four cases (5%, calcific vasculopathy in three cases and parenchymal calcification in one case) [<xref ref-type="bibr" rid="CR97">97</xref>].</p>
<p id="Par30">Acute infection with Toxoplasma gondii usually is asymptomatic in children and adults, but serious clinical disease could result from a congenital infection. Infants with congenital toxoplasmosis are asymptomatic in about 70 to 90% of the cases, but they could develop sequelae during childhood or early adult life. A prospective study including 43 infants and children, with a confirmed diagnosis of congenital toxoplasmosis, showed diffuse intraparenchymatous calcifications in 28 children (65%) and the presence of calcifications in the meninges and areas of the caudate nucleus indicates a poor prognosis [<xref ref-type="bibr" rid="CR98">98</xref>].</p>
</sec>
<sec id="Sec10">
<title>Toxic exposure</title>
<p id="Par31">Although the pathophysiological mechanism of brain toxicity related to chronic lead exposure is poorly understood, it has been suggested that a prolonged exposition could cause intracranial calcifications in adults [<xref ref-type="bibr" rid="CR99">99</xref>]. Tonge and coll [<xref ref-type="bibr" rid="CR100">100</xref>] showed microscopically a significant correlation between cerebellar calcification and increased lead levels in bones in 10 to 15% of autopsies performed between 1951 and 1976. Neuroimaging findings include multifocal curvilinear calcifications in the subcortical white matter of both cerebral and cerebellar hemispheres and the involvement of basal ganglia, bilaterally [<xref ref-type="bibr" rid="CR101">101</xref>]. A post-mortem neuropathological study on a 72-year-old man who was diagnosed with lead poisoning showed macroscopic and microscopic calcifications in the cerebellum, cerebral cortex, gray–white junction, white matter, basal ganglia, and thalamic regions. The pattern of calcification included deposits consisting of small calcospherites in the walls of the capillaries and in the tunica media of small- to medium-caliber vessels [<xref ref-type="bibr" rid="CR102">102</xref>]. Basal ganglia calcifications involving globus pallidus may occur also in carbon monoxide poisoning [<xref ref-type="bibr" rid="CR103">103</xref>].</p>
</sec>
<sec id="Sec11">
<title>Disimmunopathies</title>
<p id="Par32">Systemic lupus erythematosus (SLE) is a chronic autoimmune multifactorial disease characterized by multisystemic involvement and diverse clinical features [<xref ref-type="bibr" rid="CR104">104</xref>]. Involvement of the nervous system with cognitive and/or psychiatric, central, and peripheral nervous is referred to as neurolupus [<xref ref-type="bibr" rid="CR105">105</xref>] and has been reported to be associated with brain calcification up to 30% of patients [<xref ref-type="bibr" rid="CR106">106</xref>]. Brain CT scan showed the presence of diffuse calcifications over the basal ganglia, centrum semiovale, and cerebellum, and the involvement of the cerebral cortex [<xref ref-type="bibr" rid="CR107">107</xref>–<xref ref-type="bibr" rid="CR109">109</xref>].</p>
</sec>
</sec>
<sec id="Sec12">
<title>Other conditions</title>
<p id="Par33">Basal ganglia calcifications related to other genetically determined conditions occur mainly with other systemic signs or symptoms.</p>
<sec id="Sec13">
<title>Pseudohypoparathyroidism</title>
<p id="Par34">Brain calcifications can also occur in genetically determined forms of resistance to PTH defined as pseudohypoparathyroidism, in which clinical and laboratorial hypoparathyroidism findings (hypocalcemia, hyperphosphatemia) are associated with normal or high plasmatic levels of PTH that is normally produced [<xref ref-type="bibr" rid="CR77">77</xref>]. This condition had been linked with mutation in GNAS (guanine nucleotide binding protein G alpha stimulating) and STX 16 (syntaxin), causing the occurrence of seizures, movement disorders with or without cognitive impairment, or psychiatric symptoms together with other clinical features such as short stature and skeletal abnormalities [<xref ref-type="bibr" rid="CR110">110</xref>].</p>
</sec>
<sec id="Sec14">
<title>Cockayne syndromes</title>
<p id="Par35">Cockayne syndrome (CS) type I (moderate CS) is characterized by basal ganglia calcifications, developmental abnormalities in the first two years, progressive impairment of vision, hearing, and central and peripheral nervous system functions leading to severe disability. CS type II (severe CS or early-onset CS) overlaps with cerebro-oculo-facioskeletal syndrome (COFS) or Pena-Shokeir syndrome type I and it is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. CS type III (mild CS or late-onset CS) is characterized by essentially normal growth and cognitive development or by late onset [<xref ref-type="bibr" rid="CR111">111</xref>].</p>
<p id="Par36">Cockayne syndromes can result from mutations in either the excision repair cross-complementation group 6 (ERCC6) gene or the ERCC8 gene involved in repairing damaged DNA, but early reports found no obvious genotype-phenotype correlations for mutations in either <italic>ERCC8</italic> or <italic>ERCC6</italic>, suggesting that the clinical variability within the CS spectrum may not be accounted for gene mutation alone [<xref ref-type="bibr" rid="CR112">112</xref>]. CS is classified among the childhood leukodystrophies, and brain imaging findings are cardinal features suggesting the diagnosis of CS [<xref ref-type="bibr" rid="CR113">113</xref>]. The main clinical findings are increased tone/spasticity, hyper- or hyporeflexia, abnormal gait or inability to walk, ataxia, tremor, seizures and behavioral abnormalities, and hearing and visual loss [<xref ref-type="bibr" rid="CR111">111</xref>, <xref ref-type="bibr" rid="CR112">112</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]. In patients with classic CS, symmetric, attenuated, and homogeneous putaminal calcifications are usually predominant, while in patients with severe CS II and COFS, diffuse cortical calcifications at the depths of the sulci are associated with the putaminal calcifications [<xref ref-type="bibr" rid="CR113">113</xref>].</p>
</sec>
<sec id="Sec15">
<title>Aicardi-Goutières syndrome</title>
<p id="Par37">Aicardi-Goutières syndrome (AGS) is a familial progressive early-onset encephalopathy characterized by physical and mental abnormalities, seizures, calcification of basal ganglia (particularly putamen, pallidus and thalamus), leukodystrophy, cerebral atrophy, and progressive microcephaly [<xref ref-type="bibr" rid="CR115">115</xref>]. Crow and coll have identified mutations in 4 genes encoding the exonuclease TREX1 (<italic>AGS1</italic>) on chromosome 3 and all 3 subunits of the hetero-trimeric ribonuclease H2 (RNaseH2) endonuclease complex (<italic>AGS2</italic> on chromosome 13, <italic>AGS3</italic> on chromosome 11, <italic>AGS4</italic> on chromosome 19) as responsible for the AGS phenotype [<xref ref-type="bibr" rid="CR116">116</xref>]. These genes provide transcript for nucleases and absent or impaired enzyme function may result in the accumulation of unneeded DNA and RNA in cells [<xref ref-type="bibr" rid="CR117">117</xref>]. In AGS, calcifications are more frequently small and punctuate in the basal ganglia and in the deep and periventricular white matter [<xref ref-type="bibr" rid="CR118">118</xref>].</p>
</sec>
<sec id="Sec16">
<title>Mitochondrial diseases</title>
<p id="Par38">Mitochondrial disorders could be characterized by abnormalities in calcium metabolism and high level of serum lactic acid. Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and myoclonic epilepsy with ragged red fibers (MERRF) have been associated with calcification of the basal ganglia occurring up to 13% of cases [<xref ref-type="bibr" rid="CR119">119</xref>]. MELAS is due an A-G point mutation at nucleotide 3243 (A3243G) in the tRNA<sup>Leu</sup> gene of mtDNA (MTTL) [<xref ref-type="bibr" rid="CR120">120</xref>]. A family with features of both MERRF and MELAS (MERRF/MELAS overlap syndrome) and a mutation in the gene MTTS1 (transfer RNA, mitochondrial, serine 1) whose members showed bilateral calcification of basal ganglia and cerebral atrophy has been described [<xref ref-type="bibr" rid="CR121">121</xref>].</p>
</sec>
<sec id="Sec17">
<title>Coat’s disease</title>
<p id="Par39"><italic>Coat’s disease</italic> is an eye disorder characterized by abnormal development of the retinal blood vessels. The underlying cause is not known but some cases may be due to somatic mutations in the <italic>NDP</italic> gene (Norrie Disease Pseudoglioma, encoding for a protein called norrin, participating in chemical signaling of cells) [<xref ref-type="bibr" rid="CR122">122</xref>]. Goutières et al. described two children with bilateral Coats’ disease associated with cerebral calcifications in the basal ganglia and deep white matter, asymptomatic at the time of their discovery [<xref ref-type="bibr" rid="CR123">123</xref>].</p>
</sec>
<sec id="Sec18">
<title>Neurodegenerative conditions</title>
<p id="Par40">Some neurodegenerative conditions such as neurodegeneration with brain iron accumulation (NBIA) and neuroferritinopathies could present basal ganglia calcification due to excess iron storage, neuroinflammation, or cystic degeneration, mainly in putamen or globus pallidus [<xref ref-type="bibr" rid="CR13">13</xref>]. Recently, two cases of genetically confirmed pantothenate kinase-associated neurodegeneration (PKAN) with globus pallidus calcification have been described [<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR125">125</xref>]. Basal ganglia calcifications have also been described in two patients with beta propeller-associated neurodegeneration (BPAN), a recently characterized type of NBIA caused by mutations in the tryptophan-aspartic acid (W-D) dipeptide repeats domain 45 (WDR45) gene encoding for β propeller protein, presenting with progressive dystonia and dementia and autistic regression and seizures, respectively. Neuroimaging findings showed the presence of bilateral dense calcification of globus pallidus revealed by CT scan together with symmetric MRI T2 hypointensity of bilateral globi pallidi and substantia nigra [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>]. PKAN and other NBIA syndromes should be considered in the differential diagnoses of basal ganglia calcification especially when calcification is limited to the globus pallidus with early onset of neuropsychiatric features characterized by slowly progressive extrapyramidal signs and psychiatric symptoms [<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR125">125</xref>].</p>
<p id="Par41">Recently, Shi and coll [<xref ref-type="bibr" rid="CR128">128</xref>] recently described a novel mutation in Ras-related protein 39B (RAB39B) as a potential cause of X-linked juvenile parkinsonism with very early onset presenting with bilateral pallidum calcifications. RAB39B, a member of the RAS oncogene family, consists of 2 exons on the chromosome Xq28 and plays an essential role in neuronal maintenance and survival [<xref ref-type="bibr" rid="CR128">128</xref>].</p>
</sec>
</sec>
</sec>
<sec id="Sec19">
<title>Diagnostic approach</title>
<p id="Par42">The detection of bilateral basal ganglia calcifications on CT/MRI investigations, together with a progressive neurologic dysfunctions, which generally includes movement disorders and/or neuropsychiatric manifestations, should start a diagnostic workup based on key points, orienting in the differential diagnosis between primary or secondary forms [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
<p id="Par43">Since idiopathic or secondary hypoparathyroidism are the most common causes of basal ganglia calcification in adulthood, disorders of Ca/P metabolism and parathyroid abnormalities should be excluded [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]. Specific blood test is crucial to exclude poisoning-related brain calcifications, infections, or autoimmune conditions [<xref ref-type="bibr" rid="CR129">129</xref>]. If secondary causes are excluded and the family history is suggestive of autosomal dominant inheritance, molecular genetic testing should be considered [<xref ref-type="bibr" rid="CR13">13</xref>]. SLC20A2 is the most common gene involved followed by PDGFB and PDGFRB [<xref ref-type="bibr" rid="CR54">54</xref>]. Finally, age-related and asymptomatic physiological basal ganglia calcifications have been detected up to 20% of routine CT scan and the radiological pattern could distinguish them from pathological calcifications [<xref ref-type="bibr" rid="CR3">3</xref>]. Usually, physiological calcifications involve the globus pallidus and are bilateral and faint; other regions that may be involved include the pineal gland, falx, and choroid plexus [<xref ref-type="bibr" rid="CR129">129</xref>].</p>
</sec>
<sec id="Sec20">
<title>Therapy</title>
<p id="Par44">Management strategies and treatment mainly focus on symptomatic relief and are strictly related to the clinical features. Since selective removal of deposited calcium from the brain without effecting calcium from bone and other tissues appears to be an impossible task [<xref ref-type="bibr" rid="CR1">1</xref>], pharmacological treatment should be used to improve neurological and/or psychiatric symptoms and to try to remove underlying cause [<xref ref-type="bibr" rid="CR10">10</xref>]. The presence of an abnormal Ca/P metabolism or parathyroid dysfunction should be corrected with intravenous calcium gluconate or long-term oral therapy with calcium and calcitriol, with the improvement of extrapyramidal signs and chronic paresthesia or seizures in most cases [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR86">86</xref>–<xref ref-type="bibr" rid="CR88">88</xref>]. Additionally, appropriate antiepileptic drugs for seizures should be used [<xref ref-type="bibr" rid="CR89">89</xref>]. Antiparkinsonian drugs could be useful for patients with parkinsonism, even if pharmacological response could be minimal [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR88">88</xref>, <xref ref-type="bibr" rid="CR130">130</xref>]. Patients who develop psychiatric features should be treated with mood stabilizer or antipsychotic drugs. Neuroleptic medication should be used cautiously, since they may exacerbate extrapyramidal symptoms, while a poor response to neuroleptics was obtained in a family with brain calcifications and psychotic manifestations [<xref ref-type="bibr" rid="CR10">10</xref>]. Loeb et al. used disodium etidronate in one patient, determining symptomatic benefit without reduction in calcification [<xref ref-type="bibr" rid="CR130">130</xref>]. Recently, a case series of 7 patients treated with alendronate showed good tolerance and evidence of improvements in symptoms (tremor and headache) and stability by some patients, suggesting the effectiveness of alendronate therapy in basal ganglia calcification [<xref ref-type="bibr" rid="CR131">131</xref>].</p>
</sec>
<sec id="Sec21">
<title>Conclusions</title>
<p id="Par45">Basal ganglia calcification is a rare neurodegenerative disorder occurring as primary/idiopathic disease or as secondary manifestation of a condition, leading to an abnormal deposition of calcium in peculiar brain structures. This condition is associated with a variety of neuropsychiatric signs and symptoms and could be unnoticed for years. Recently, genetic mutations have been identified helping in distinguish between idiopathic and secondary forms, associated with different conditions. Clinically, parkinsonism or other movement disorders appear to be the most common presentation, together with seizures and cognitive decline. CT scan is considered the gold standard for diagnosis identifying calcifications as hyperdense lesions typically bilateral and symmetrical, most frequently involving basal ganglia, but also dentate nuclei, thalamus, and subcortical white matter. The anatomical pattern of calcifications does not seem to be directly correlated to the clinical phenotype. Further studies are needed in order to clarify pathological mechanisms of calcium deposition and identify specific therapeutic strategies.</p>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>
<bold>Publisher’s note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>
<bold>Change history</bold>
</p>
<p>8/23/2019</p>
<p>The article “&lt;Emphasis Type="Italic"&gt;Basal ganglia calcifications (Fahr’s syndrome): related conditions and clinical features, written by Giulia Donzuso, Giovanni Mostile, Alessandra Nicoletti, and Mario Zappia&lt;/Emphasis&gt;”, was originally published electronically on the publisher’s internet portal (currently SpringerLink).</p>
</fn>
</fn-group>
<notes notes-type="ethics">
<title>Compliance with ethical standards</title>
<notes notes-type="COI-statement">
<title>Conflict of interest</title>
<p>The author declares that she has no conflict of interest.</p>
</notes>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manyam</surname>
<given-names>BV</given-names>
</name>
</person-group>
<article-title>What is and what is not ‘Fahr’s disease’</article-title>
<source/>Parkinsonism Relat Disord
          <year>2005</year>
<volume>11</volume>
<fpage>73</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">15734663</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savino</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Soavi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Capatti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Borrelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vigna</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Passaro</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zuliani</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Bilateral strio-pallido-dentate calcinosis (Fahr’s disease): report of seven cases and revision of literature</article-title>
<source/>BMC Neurol
          <year>2016</year>
<volume>16</volume>
<fpage>165</fpage>
<pub-id pub-id-type="pmid">27608765</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Asano</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kanematsu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hoshi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Akaiwa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shimohata</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nishizawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Inuzuka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hozumi</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>High frequency of calcification in basal ganglia on brain computed tomography images in Japanese older adults</article-title>
<source/>Geriatr Gerontol Int
          <year>2013</year>
<volume>13</volume>
<issue>3</issue>
<fpage>706</fpage>
<lpage>710</lpage>
<pub-id pub-id-type="pmid">23279700</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simoni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pantoni</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pracucci</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Palmertz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Gustafson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Skoog</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Prevalence of CT-detected cerebral abnormalities in an elderly Swedish population sample</article-title>
<source/>Acta Neurol Scand
          <year>2008</year>
<volume>118</volume>
<issue>4</issue>
<fpage>260</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="pmid">18336623</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fahr</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Idiopathische verkalkung der hirngefässe</article-title>
<source/>Zentrabl Allg Pathol
          <year>1930</year>
<volume>50</volume>
<fpage>129</fpage>
<lpage>133</lpage>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delacour</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Ossification des capillaires du cerveau</article-title>
<source/>Ann Med Psychol
          <year>1850</year>
<volume>2</volume>
<fpage>458</fpage>
<lpage>461</lpage>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Bamberger</surname>
</name>
<name>
<surname>Von Rokitansky</surname>
<given-names>K</given-names>
</name>
</person-group>
<source/>Lehrbuch der Pathologischen Anatomie
          <year>1856</year>
<publisher-loc>Vienna</publisher-loc>
<publisher-name>Wilhelm Braumuller</publisher-name>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caraceni</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Broggi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Avanzini</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Familial idiopathic basal ganglia calcification exhibiting “dystonia musculorum deformans” features</article-title>
<source/>Eur Neurol
          <year>1974</year>
<volume>12</volume>
<fpage>351</fpage>
<lpage>359</lpage>
<pub-id pub-id-type="pmid">4448193</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manyam</surname>
<given-names>BV</given-names>
</name>
<name>
<surname>Bhatt</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>Devleschoward</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Calne</surname>
<given-names>DB</given-names>
</name>
</person-group>
<article-title>Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies</article-title>
<source/>Ann Neurol
          <year>1992</year>
<volume>31</volume>
<fpage>379</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="pmid">1586138</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<mixed-citation publication-type="other">Sobrido MJ, Coppola G, Oliveira J, Hopfer S, Geschwind DH (1993–2014) Primary familial brain calcification. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT et al (eds) GeneReviews™. University of Washington, Seattle. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK1421/">http://www.ncbi.nlm.nih.gov/books/NBK1421/</ext-link>. Accessed June 2019</mixed-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicolas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Charbonnier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Campion</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Estimation of minimal disease prevalence from population genomic data: application to primary familial brain calcification</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2018</year>
<volume>177</volume>
<issue>1</issue>
<fpage>68</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">29152850</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Mendes de Oliveira</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>The need for consensus on primary familial brain calcification nomenclature</article-title>
<source/>J Neuropsychiatry Clin Neurosci
          <year>2018</year>
<volume>30</volume>
<issue>4</issue>
<fpage>291</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="pmid">30045681</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saleem</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aslam</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Anwar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Anwar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saleem</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Saleem</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rehmani</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Fahr’s syndrome: literature review of current evidence</article-title>
<source/>Orphanet J Rare Dis
          <year>2013</year>
<volume>8</volume>
<issue>8</issue>
<fpage>156</fpage>
<pub-id pub-id-type="pmid">24098952</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shoback</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Bilezikian</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Dempster</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dralle</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Peacock</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Raffaelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Thakker</surname>
<given-names>RV</given-names>
</name>
<name>
<surname>Vokes</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bouillon</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Presentation of hypoparathyroidism: etiologies and clinical features</article-title>
<source/>J Clin Endocrinol Metab
          <year>2016</year>
<volume>101</volume>
<issue>6</issue>
<fpage>2300</fpage>
<lpage>2312</lpage>
<pub-id pub-id-type="pmid">26943721</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valdés Hernández</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Maconick</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Wardlaw</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Identification of mineral deposits in the brain on radiological images: a systematic review</article-title>
<source/>Eur Radiol
          <year>2012</year>
<volume>22</volume>
<issue>11</issue>
<fpage>2371</fpage>
<lpage>2381</lpage>
<pub-id pub-id-type="pmid">22688125</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sahin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Solak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Genc</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kulu</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Fahr disease: use of susceptibility-weighted imaging for diagnostic dilemma with magnetic resonance imaging</article-title>
<source/>Quant Imaging Med Surg
          <year>2015</year>
<volume>5</volume>
<issue>4</issue>
<fpage>628</fpage>
<lpage>632</lpage>
<pub-id pub-id-type="pmid">26435928</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginat</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Meyers</surname>
<given-names>SP</given-names>
</name>
</person-group>
<article-title>Intracranial lesions with high signal intensity on T1-weighted MR images: differential diagnosis</article-title>
<source/>Radiographics
          <year>2012</year>
<volume>32</volume>
<issue>2</issue>
<fpage>499</fpage>
<lpage>516</lpage>
<pub-id pub-id-type="pmid">22411945</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henkelman</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Watts</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Kucharczyk</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>High signal intensity in MR images of calcified brain tissue</article-title>
<source/>Radiology
          <year>1991</year>
<volume>179</volume>
<issue>1</issue>
<fpage>199</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="pmid">1848714</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valdés Hernández</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Glatz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kiker</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Dickie</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Aribisala</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Royle</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Muñoz Maniega</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bastin</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Deary</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Wardlaw</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Differentiation of calcified regions and iron deposits in the ageing brain on conventional structural MR images</article-title>
<source/>J Magn Reson Imaging
          <year>2014</year>
<volume>40</volume>
<issue>2</issue>
<fpage>324</fpage>
<lpage>333</lpage>
<pub-id pub-id-type="pmid">24923620</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gronemeyer</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Langston</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Hanna</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Langston</surname>
<given-names>JW</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>MR imaging detection of calcified intracranial lesions and differentiation from iron-laden lesions</article-title>
<source/>J Magn Reson Imaging
          <year>1992</year>
<volume>2</volume>
<issue>3</issue>
<fpage>271</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="pmid">1627861</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avrahami</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cohn</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Feibel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tadmor</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>MRI demonstration and CT correlation of the brain in patients with idiopathic intracerebral calcification</article-title>
<source/>J Neurol
          <year>1994</year>
<volume>241</volume>
<issue>6</issue>
<fpage>381</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="pmid">7931433</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kıroğlu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Callı</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Karabulut</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Oncel</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Intracranial calcifications on CT</article-title>
<source/>Diagn Interv Radiol
          <year>2010</year>
<volume>16</volume>
<issue>4</issue>
<fpage>263</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="pmid">20027545</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hempel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Henze</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Berghoff</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ody</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schröder</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>PET findings and neuropsychological deficits in a case of Fahr’s disease</article-title>
<source/>Psychiatry Res
          <year>2001</year>
<volume>108</volume>
<issue>2</issue>
<fpage>133</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="pmid">11738547</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fukumitsu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tsuchida</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Uchiyama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Matsui</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Imaging of bilateral striopallidodentate calcinosis</article-title>
<source/>Clin Nucl Med
          <year>2002</year>
<volume>27</volume>
<issue>10</issue>
<fpage>721</fpage>
<lpage>724</lpage>
<pub-id pub-id-type="pmid">12352115</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Ber</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Marié</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Chabot</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lalevée</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Defer</surname>
<given-names>GL</given-names>
</name>
</person-group>
<article-title>Neuropsychological and 18FDG-PET studies in a family with idiopathic basal ganglia calcifications</article-title>
<source/>J Neurol Sci
          <year>2007</year>
<volume>258</volume>
<issue>1–2</issue>
<fpage>115</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="pmid">17481663</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saito</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ishiwata</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ishii</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Isse</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Neuroradiologic evidence of pre-synaptic and post-synaptic nigrostriatal dopaminergic dysfunction in idiopathic basal ganglia calcification: a case report</article-title>
<source/>J Neuroimaging
          <year>2010</year>
<volume>20</volume>
<issue>2</issue>
<fpage>189</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="pmid">19021829</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paghera</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Caobelli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Giubbini</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>123I-ioflupane SPECT in Fahr disease</article-title>
<source/>J Neuroimaging
          <year>2013</year>
<volume>23</volume>
<issue>1</issue>
<fpage>157</fpage>
<lpage>158</lpage>
<pub-id pub-id-type="pmid">21410813</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paschali</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lakiotis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Messinis</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Markaki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Constantoyannis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ellul</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vassilakos</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Dopamine transporter SPECT/CT and perfusion brain SPECT imaging in idiopathic basal ganglia calcinosis</article-title>
<source/>Clin Nucl Med
          <year>2009</year>
<volume>34</volume>
<issue>7</issue>
<fpage>421</fpage>
<lpage>423</lpage>
<pub-id pub-id-type="pmid">19542944</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calabria</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ciccariello</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Falcone</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cascini</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Schillaci</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>A case of Fahr’s disease examined by multi-modal imaging</article-title>
<source/>Eur J Nucl Med Mol Imaging
          <year>2015</year>
<volume>42</volume>
<issue>13</issue>
<fpage>2098</fpage>
<lpage>2099</lpage>
<pub-id pub-id-type="pmid">26264368</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donzuso</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sciacca</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mostile</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Patti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zappia</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Extensive bilateral striopallidodentate calcinosis: a 50 years history of hypoparathyroidism presenting like a parkinsonian syndrome</article-title>
<source/>J Neurol
          <year>2016</year>
<volume>263</volume>
<issue>9</issue>
<fpage>1876</fpage>
<lpage>1879</lpage>
<pub-id pub-id-type="pmid">27485169</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicolas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Marguet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Laquerrière</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mendes de Oliveira</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Hannequin</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Microangiopathy in primary familial brain calcification: evidence from skin biopsies</article-title>
<source/>Neurol Genet
          <year>2017</year>
<volume>3</volume>
<issue>2</issue>
<fpage>e134</fpage>
<pub-id pub-id-type="pmid">28210710</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smeyers-Verbeke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Michotte</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pelsmaeckers</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lowenthal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Massart</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Dekegel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Karcher</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The chemical composition of idiopathic nonarteriosclerotic cerebral calcifications</article-title>
<source/>Neurology
          <year>1975</year>
<volume>25</volume>
<issue>1</issue>
<fpage>48</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="pmid">122856</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wider</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Schweitzer</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Broderick</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</name>
</person-group>
<article-title>Familial idiopathic basal ganglia calcification: a challenging clinical-pathological correlation</article-title>
<source/>J Neurol
          <year>2009</year>
<volume>256</volume>
<fpage>839</fpage>
<lpage>842</lpage>
<pub-id pub-id-type="pmid">19252803</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miklossy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mackenzie</surname>
<given-names>IR</given-names>
</name>
<name>
<surname>Dorovini-Zis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Calne</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</name>
<name>
<surname>Klegeris</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McGeer</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Severe vascular disturbance in a case of familial brain calcinosis</article-title>
<source/>Acta Neuropathol
          <year>2005</year>
<volume>09</volume>
<issue>6</issue>
<fpage>643</fpage>
<lpage>653</lpage>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hondo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Konno</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Uchiyama</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ikeuchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kakita</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Familial idiopathic basal ganglia calcification: histopathologic features of an autopsied patient with an SLC20A2 mutation</article-title>
<source/>Neuropathology
          <year>2016</year>
<volume>36</volume>
<issue>4</issue>
<fpage>365</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="pmid">26635128</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwase</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hashizume</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yazawa</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nokura</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Intracranial vascular calcification with extensive white matter changes in an autopsy case of pseudopseudohypoparathyroidism</article-title>
<source/>Neuropathology
          <year>2019</year>
<volume>39</volume>
<issue>1</issue>
<fpage>39</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">30430658</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Preusser</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kitzwoegerer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Budka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Brugger</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Bilateral striopallidodentate calcification (Fahr’s syndrome) and multiple system atrophy in a patient with longstanding hypoparathyroidism</article-title>
<source/>Neuropathology
          <year>2007</year>
<volume>27</volume>
<issue>5</issue>
<fpage>453</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="pmid">18018479</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemos</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Legati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jenkinson</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Livingston</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Crow</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Campion</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Update and mutational analysis of SLC20A2: a major cause of primary familial brain calcification</article-title>
<source/>Hum Mutat
          <year>2015</year>
<volume>36</volume>
<issue>5</issue>
<fpage>489</fpage>
<lpage>495</lpage>
<pub-id pub-id-type="pmid">25726928</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Loginov</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease)</article-title>
<source/>Am J Hum Genet
          <year>1999</year>
<volume>65</volume>
<fpage>764</fpage>
<lpage>772</lpage>
<pub-id pub-id-type="pmid">10441584</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volpato</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>De Grandi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Buffone</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Facheris</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gebert</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Schifferle</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schönhuber</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hicks</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pramstaller</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>2q37 as a susceptibility locus for idiopathic basal ganglia calcification (IBGC) in a large South Tyrolean family</article-title>
<source/>J Mol Neurosci
          <year>2009</year>
<volume>39</volume>
<fpage>346</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="pmid">19757205</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taglia</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mignarri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Olgiati</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Menci</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Petrocelli</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Breedveld</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Scaglione</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Martinelli</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Federico</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bonifati</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Dotti</surname>
<given-names>MT</given-names>
</name>
</person-group>
<article-title>Primary familial brain calcification: genetic analysis and clinical spectrum</article-title>
<source/>Mov Disord
          <year>2014</year>
<volume>29</volume>
<issue>13</issue>
<fpage>1691</fpage>
<lpage>1695</lpage>
<pub-id pub-id-type="pmid">25284758</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Legati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Giovannini</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lopez-Sanchez</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Quintans</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export</article-title>
<source/>Nat Genet
          <year>2015</year>
<volume>47</volume>
<fpage>579</fpage>
<lpage>581</lpage>
<pub-id pub-id-type="pmid">25938945</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anheim</surname>
<given-names>M</given-names>
</name>
<name>
<surname>López-Sánchez</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Giovannini</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Touhami</surname>
<given-names>J</given-names>
</name>
<name>
<surname>N’Guyen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rudolf</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Thibault-Stoll</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Frebourg</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hannequin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Campion</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Battini</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Sitbon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>XPR1 mutations are a rare cause of primary familial brain calcification</article-title>
<source/>J Neurol
          <year>2016</year>
<volume>263</volume>
<fpage>1559</fpage>
<lpage>1564</lpage>
<pub-id pub-id-type="pmid">27230854</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Sears</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Lemos</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Quintáns</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Spiteri</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nevarez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mamah</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zatz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Fullerton</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Adair</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Berner</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Bower</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brodaty</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Carmona</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Dobricić</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Fogel</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>García-Estevez</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goudreau</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Hopfer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Janković</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jaumà</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jen</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Kirdlarp</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Klepper</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kostić</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Linglart</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Maisenbacher</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Manyam</surname>
<given-names>BV</given-names>
</name>
<name>
<surname>Mazzoni</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Miedzybrodzka</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Mitarnun</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Novaković</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Paucar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Paulson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Svenningsson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tuite</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vitek</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wetchaphanphesat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schofield</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>JRM</given-names>
</name>
<name>
<surname>Sobrido</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification</article-title>
<source/>Neurogenetics
          <year>2013</year>
<volume>14</volume>
<issue>1</issue>
<fpage>11</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">23334463</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grütz</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Volpato</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Domingo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Alvarez-Fischer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gebert</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Schifferle</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Buffone</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wszolek</surname>
<given-names>ZK</given-names>
</name>
<name>
<surname>Rademakers</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ferbert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hicks</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pramstaller</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Westenberger</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Primary familial brain calcification in the ‘IBGC2’ kindred: all linkage roads lead to SLC20A2</article-title>
<source/>Mov Disord
          <year>2016</year>
<volume>31</volume>
<issue>12</issue>
<fpage>1901</fpage>
<lpage>1904</lpage>
<pub-id pub-id-type="pmid">27671522</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taglia</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bonifati</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mignarri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dotti</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Federico</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Primary familial brain calcification: update on molecular genetics</article-title>
<source/>Neurol Sci
          <year>2015</year>
<volume>36</volume>
<issue>5</issue>
<fpage>787</fpage>
<lpage>794</lpage>
<pub-id pub-id-type="pmid">25686613</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gagliardi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Annesi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Perrotta</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pustorino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Iannello</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tarantino</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gambardella</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Quattrone</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A new SLC20A2 mutation identified in southern Italy family with primary familial brain calcification</article-title>
<source/>Gene
          <year>2015</year>
<volume>568</volume>
<issue>1</issue>
<fpage>109</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="pmid">25958344</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>da Silva</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Analysis of gene expression pattern and neuroanatomical correlates for SLC20A2 (PiT-2) shows a molecular network with potential impact in idiopathic basal ganglia calcification (“Fahr’s disease”)</article-title>
<source/>J Mol Neurosci
          <year>2013</year>
<volume>50</volume>
<issue>2</issue>
<fpage>280</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="pmid">23576097</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keller</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Westenberger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sobrido</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>García-Murias</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Domingo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sears</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Lemos</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Ordoñez-Ugalde</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>da Cunha</surname>
<given-names>JEG</given-names>
</name>
<name>
<surname>Rushing</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Hugelshofer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wurnig</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Kaech</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Reimann</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lohmann</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dobričić</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Carracedo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Petrović</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Miyasaki</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Abakumova</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mäe</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Raschperger</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zatz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zschiedrich</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Klepper</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Spiteri</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Prieto</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Navas</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Preuss</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dering</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Janković</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Paucar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Svenningsson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Saliminejad</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Khorshid</surname>
<given-names>HRK</given-names>
</name>
<name>
<surname>Novaković</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Aguzzi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Boss</surname>
<given-names>A</given-names>
</name>
<name>
<surname>le Ber</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Defer</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hannequin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kostić</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Campion</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Betsholtz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>JRM</given-names>
</name>
</person-group>
<article-title>Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice</article-title>
<source/>Nat Genet
          <year>2013</year>
<volume>45</volume>
<fpage>1077</fpage>
<lpage>1082</lpage>
<pub-id pub-id-type="pmid">23913003</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicolas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pottier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Maltête</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification</article-title>
<source/>Neurology
          <year>2013</year>
<volume>80</volume>
<fpage>181</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="pmid">23255827</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>XP</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>XX</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>HZ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Biallelic mutations in MYORG cause autosomal recessive primary familial brain calcification</article-title>
<source/>Neuron
          <year>2018</year>
<volume>98</volume>
<issue>6</issue>
<fpage>1116</fpage>
<lpage>1123.e5</lpage>
<pub-id pub-id-type="pmid">29910000</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evaluation of MYORG mutations as a novel cause of primary familial brain calcification</article-title>
<source/>Mov Disord
          <year>2018</year>
<volume>34</volume>
<issue>2</issue>
<fpage>291</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="pmid">30589467</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Roca</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chumchim</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dokuru</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Van Berlo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>De Michele</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Primary familial brain calcification caused by a novel homozygous MYORG mutation in a consanguineous Italian family</article-title>
<source/>Neurogenetics
          <year>2019</year>
<volume>20</volume>
<issue>2</issue>
<fpage>99</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="pmid">30895394</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batla</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Schottlaender</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Erro</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Balint</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bhatia</surname>
<given-names>KP</given-names>
</name>
</person-group>
<article-title>Deconstructing Fahr’s disease/syndrome of brain calcification in the era of new genes</article-title>
<source/>Parkinsonism Relat Disord
          <year>2017</year>
<volume>37</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">28162874</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Capaldo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>D’Amico</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Colavito</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Elefante</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Straccia</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ugga</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Puoti</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>A novel SLC20A2 gene mutation causing primary familial brain calcification in an Ukrainian patient</article-title>
<source/>Neurol Sci
          <year>2019</year>
<volume>40</volume>
<issue>6</issue>
<fpage>1283</fpage>
<lpage>1285</lpage>
<pub-id pub-id-type="pmid">30607525</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamquet</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Legati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hemelsoet</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vanakker</surname>
<given-names>OM</given-names>
</name>
</person-group>
<article-title>A likely pathogenic variant in the SLC20A2 gene presenting with progressive myoclonus</article-title>
<source/>Ann Clin Transl Neurol
          <year>2019</year>
<volume>6</volume>
<issue>3</issue>
<fpage>605</fpage>
<lpage>609</lpage>
<pub-id pub-id-type="pmid">30911583</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gagliardi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Iannello</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Colica</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Annesi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Quattrone</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A SLC20A2 mutation identified in an asymptomatic patient with brain calcification</article-title>
<source/>J Neurol Sci
          <year>2017</year>
<volume>372</volume>
<fpage>70</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="pmid">28017251</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paucar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Almqvist</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jelic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hagman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jörneskog</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Holmin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Björkhem</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Svenningsson</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>A SLC20A2 gene mutation carrier displaying ataxia and increased levels of cerebrospinal fluid phosphate</article-title>
<source/>J Neurol Sci
          <year>2017</year>
<volume>375</volume>
<fpage>245</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="pmid">28320140</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>JY</given-names>
</name>
</person-group>
<article-title>A PDGFB mutation causes paroxysmal nonkinesigenic dyskinesia with brain calcification</article-title>
<source/>Mov Disord
          <year>2017</year>
<volume>32</volume>
<issue>7</issue>
<fpage>1104</fpage>
<lpage>1106</lpage>
<pub-id pub-id-type="pmid">28556368</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paucar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Almqvist</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Saeed</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bergendal</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ygge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Holmin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Björkhem</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Svenningsson</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Progressive brain calcifications and signs in a family with the L9R mutation in the PDGFB gene</article-title>
<source/>Neurol Genet
          <year>2016</year>
<volume>2</volume>
<issue>4</issue>
<fpage>e84</fpage>
<pub-id pub-id-type="pmid">27433546</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathorne</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Sørensen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fagerberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bode</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hertz</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>A novel PDGFRB sequence variant in a family with a mild form of primary familial brain calcification: a case report and a review of the literature</article-title>
<source/>BMC Neurol
          <year>2019</year>
<volume>19</volume>
<issue>1</issue>
<fpage>60</fpage>
<pub-id pub-id-type="pmid">30979360</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>XP</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>XX</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>HZ</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>QJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Novel mutations of PDGFRB cause primary familial brain calcification in Chinese families</article-title>
<source/>J Hum Genet
          <year>2017</year>
<volume>62</volume>
<issue>7</issue>
<fpage>697</fpage>
<lpage>701</lpage>
<pub-id pub-id-type="pmid">28298627</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>López-Sánchez</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Maltête</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Charif</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ayrignac</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of XPR1/SLC53A1 variants located outside of the SPX domain in patients with primary familial brain calcification</article-title>
<source/>Sci Rep
          <year>2019</year>
<volume>9</volume>
<issue>1</issue>
<fpage>6776</fpage>
<pub-id pub-id-type="pmid">31043717</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>XX</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>XH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>XP</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>HZ</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>YB</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>QY</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>XJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>DQ</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>HX</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>XQ</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>XP</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Spectrum of SLC20A2, PDGFRB, PDGFB, and XPR1 mutations in a large cohort of patients with primary familial brain calcification</article-title>
<source/>Hum Mutat
          <year>2019</year>
<volume>40</volume>
<issue>4</issue>
<fpage>392</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="pmid">30609140</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicolas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Charbonnier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>de Lemos</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Guillin</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Wallon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Legati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Frebourg</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Campion</surname>
<given-names>D</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>JRM</given-names>
</name>
<name>
<surname>Hannequin</surname>
<given-names>D</given-names>
</name>
<collab>the collaborators from the French IBGC study Group</collab>
</person-group>
<article-title>Brain calcification process and phenotypes according to age and sex: lessons from SLC20A2, PDGFB and PDGFRB mutation carriers</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2015</year>
<volume>168</volume>
<fpage>586</fpage>
<lpage>594</lpage>
<pub-id pub-id-type="pmid">26129893</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tadic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Westenberger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Domingo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Alvarez-Fischer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kasten</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Primary familial brain calcification with known gene mutations: a systematic review and challenges of phenotypic characterization</article-title>
<source/>JAMA Neurol
          <year>2015</year>
<volume>72</volume>
<fpage>460</fpage>
<lpage>467</lpage>
<pub-id pub-id-type="pmid">25686319</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicolas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pottier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Charbonnier</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification</article-title>
<source/>Brain
          <year>2103</year>
<volume>136</volume>
<issue>Pt 11</issue>
<fpage>3395</fpage>
<lpage>3407</lpage>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manyam</surname>
<given-names>BV</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Narla</surname>
<given-names>KR</given-names>
</name>
</person-group>
<article-title>Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry</article-title>
<source/>Mov Disord
          <year>2001</year>
<volume>16</volume>
<fpage>258</fpage>
<lpage>264</lpage>
<pub-id pub-id-type="pmid">11295778</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiriaco</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Novellino</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Salsone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gagliardi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Quattrone</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Neuropsychological heterogeneity in patients with primary familial brain calcification due to a novel mutation in SLC20A2</article-title>
<source/>Neurol Sci
          <year>2018</year>
<volume>39</volume>
<issue>2</issue>
<fpage>379</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="pmid">28936702</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Carecchio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lemos</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Legati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sears</surname>
<given-names>RL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Primary brain calcification: an international study reporting novel variants and associated phenotypes</article-title>
<source/>Eur J Hum Genet
          <year>2018</year>
<volume>26</volume>
<issue>10</issue>
<fpage>1462</fpage>
<lpage>1477</lpage>
<pub-id pub-id-type="pmid">29955172</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grangeon</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wallon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Charbonnier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Quenez</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Rousseau</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Budowski</surname>
<given-names>C</given-names>
</name>
<collab>French PFBC study group</collab>
<etal></etal>
</person-group>
<article-title>Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype</article-title>
<source/>Brain
          <year>2019</year>
<volume>142</volume>
<issue>6</issue>
<fpage>1573</fpage>
<lpage>1586</lpage>
<pub-id pub-id-type="pmid">31009047</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Oliveira</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>de Lemos</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Mutations at the SLC20A2 gene and brain resilience in families with idiopathic basal ganglia calcification (“Fahr’s disease”)</article-title>
<source/>Front Hum Neurosci
          <year>2013</year>
<volume>7</volume>
<fpage>420</fpage>
<pub-id pub-id-type="pmid">23935574</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Westenberger</surname>
<given-names>Ana</given-names>
</name>
<name>
<surname>Balck</surname>
<given-names>Alexander</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>Christine</given-names>
</name>
</person-group>
<article-title>Primary familial brain calcifications</article-title>
<source/>Current Opinion in Neurology
          <year>2019</year>
<volume>32</volume>
<issue>4</issue>
<fpage>571</fpage>
<lpage>578</lpage>
<pub-id pub-id-type="pmid">31157644</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mu</surname>
<given-names>Weiyi</given-names>
</name>
<name>
<surname>Tochen</surname>
<given-names>Laura</given-names>
</name>
<name>
<surname>Bertsch</surname>
<given-names>Caroline</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>Harvey S</given-names>
</name>
<name>
<surname>Barañano</surname>
<given-names>Kristin W</given-names>
</name>
</person-group>
<article-title>Intracranial calcifications and dystonia associated with a novel deletion of chromosome 8p11.2 encompassing SLC20A2 and THAP1</article-title>
<source/>BMJ Case Reports
          <year>2019</year>
<volume>12</volume>
<issue>5</issue>
<fpage>e228782</fpage>
<pub-id pub-id-type="pmid">31133547</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knowles</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Santoro</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Baumer</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>Refractory focal epilepsy in a paediatric patient with primary familial brain calcification</article-title>
<source/>Seizure
          <year>2018</year>
<volume>56</volume>
<fpage>50</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="pmid">29448117</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Azem</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Hypoparathyroidism</article-title>
<source/>Best Pract Res Clin Endocrinol Metab
          <year>2012</year>
<volume>26</volume>
<issue>4</issue>
<fpage>517</fpage>
<lpage>522</lpage>
<pub-id pub-id-type="pmid">22863393</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maeda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fortes</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>UM</given-names>
</name>
<name>
<surname>Borba</surname>
<given-names>VC</given-names>
</name>
<name>
<surname>Lazaretti-Castro</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Hypoparathyroidism and pseudohypoparathyroidism</article-title>
<source/>Arq Bras Endocrinol Metabol
          <year>2006</year>
<volume>50</volume>
<issue>4</issue>
<fpage>664</fpage>
<lpage>673</lpage>
<pub-id pub-id-type="pmid">17117292</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powers</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Joy</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ruscio</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lagast</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Prevalence and incidence of hypoparathyroidism in the United States using a large claims database</article-title>
<source/>J Bone Miner Res
          <year>2013</year>
<volume>28</volume>
<issue>12</issue>
<fpage>2570</fpage>
<lpage>2576</lpage>
<pub-id pub-id-type="pmid">23737456</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goswami</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sreenivas</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ganapathy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism</article-title>
<source/>Clin Endocrinol
          <year>2012</year>
<volume>77</volume>
<fpage>200</fpage>
<lpage>206</lpage>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asari</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Passler</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kaczirek</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Scheuba</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Niederle</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Hypoparathyroidism after total thyroidectomy: a prospective study</article-title>
<source/>Arch Surg
          <year>2008</year>
<volume>143</volume>
<issue>2</issue>
<fpage>132</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="pmid">18283137</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abate</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>BL</given-names>
</name>
</person-group>
<article-title>Review of hypoparathyroidism</article-title>
<source/>Front Endocrinol
          <year>2017</year>
<volume>7</volume>
<fpage>172</fpage>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rastogi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Beauchamp</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Ladenson</surname>
<given-names>PW</given-names>
</name>
</person-group>
<article-title>Calcification of the basal ganglia in chronic hypoparathyroidism</article-title>
<source/>J Clin Endocrinol Metab
          <year>2003</year>
<volume>88</volume>
<issue>4</issue>
<fpage>1476</fpage>
<lpage>1477</lpage>
<pub-id pub-id-type="pmid">12679425</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>IS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YI</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Striopallidodentate calcification and progressive supranuclear palsy-like phenotype in a patient with idiopathic hypoparathyroidism</article-title>
<source/>J Clin Neurol
          <year>2007</year>
<volume>3</volume>
<issue>1</issue>
<fpage>57</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">19513345</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basak</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>A case report of basal ganglia calcification - a rare finding of hypoparathyroidism</article-title>
<source/>OMJ
          <year>2009</year>
<volume>24</volume>
<fpage>220</fpage>
<lpage>222</lpage>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michels</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>Parathyroid disorders</article-title>
<source/>Am Fam Physician
          <year>2013</year>
<volume>88</volume>
<issue>4</issue>
<fpage>249</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="pmid">23944728</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zisimopoulou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Siatouni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tsoukalos</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tavernarakis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gatzonis</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Extensive bilateral intracranial calcifications: a case of iatrogenic hypoparathyroidism</article-title>
<source/>Case Rep Med
          <year>2013</year>
<volume>2013</volume>
<fpage>932184</fpage>
<pub-id pub-id-type="pmid">23509468</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Bilateral striopallidodentate calcinosis secondary to postsurgical hypoparathyroidism</article-title>
<source/>BMJ Case Rep
          <year>2013</year>
<volume>13</volume>
<fpage>2013</fpage>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agarwal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lahiri</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mukhopadhyay</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Maity</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>MK</given-names>
</name>
</person-group>
<article-title>A rare cause of seizures, parkinsonian, and cerebellar signs: brain calcinosis secondary to thyroidectomy</article-title>
<source/>N Am J Med Sci
          <year>2014</year>
<volume>6</volume>
<issue>10</issue>
<fpage>540</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="pmid">25489568</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizvi</surname>
<given-names>ANA</given-names>
</name>
<name>
<surname>Beg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shamim</surname>
<given-names>MD</given-names>
</name>
</person-group>
<article-title>Widespread intracranial calcification, seizures and extrapyramidal manifestations in a case of hypoparathyroidism</article-title>
<source/>N Am J Med Sci
          <year>2012</year>
<volume>4</volume>
<fpage>369</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="pmid">22912949</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugawara</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Computed tomography anomalies associated with isolated hypoparathyroidism</article-title>
<source/>Clin Case Rep
          <year>2016</year>
<volume>4</volume>
<fpage>1205</fpage>
<lpage>1206</lpage>
<pub-id pub-id-type="pmid">27980765</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>John</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Suthar</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>Radiological features of long-standing hypoparathyroidism</article-title>
<source/>Pol J Radiol
          <year>2016</year>
<volume>81</volume>
<fpage>42</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="pmid">26937260</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendes</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Meireles-Brandão</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Meira</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Morais</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Guerra</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Primary hypoparathyroidism presenting as basal ganglia calcification secondary to extreme hypocalcemia</article-title>
<source/>Clin Pract
          <year>2018</year>
<volume>8</volume>
<issue>1</issue>
<fpage>1007</fpage>
<pub-id pub-id-type="pmid">29383229</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Sous</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Bohlega</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Al-Kawi</surname>
<given-names>MZ</given-names>
</name>
<name>
<surname>Alwatban</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McLean</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Neurobrucellosis: clinical and neuroimaging correlation</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2004</year>
<volume>3</volume>
<fpage>395</fpage>
<lpage>401</lpage>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mousa</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Muhtaseb</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Senthilselvan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Al-Mudallal</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Marafie</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>The high rate of prevalence of CT-detected basal ganglia calcification in neuropsychiatric (CNS) brucellosis</article-title>
<source/>Acta Neurol Scand
          <year>1987</year>
<volume>76</volume>
<fpage>448</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="pmid">3434203</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sulh</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Zagzag</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Reuben</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Greco</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Disseminated calcification with predominant muscle and cerebral involvement in a child with acquired immunodeficiency syndrome: a case report</article-title>
<source/>Pediatr Pathol Lab Med
          <year>1997</year>
<volume>4</volume>
<fpage>593</fpage>
<lpage>600</lpage>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Safriel</surname>
<given-names>YI</given-names>
</name>
<name>
<surname>Haller</surname>
<given-names>JO</given-names>
</name>
<name>
<surname>Lefton</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Obedian</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Imaging of the brain in the HIV-positive child</article-title>
<source/>Pediatr Radiol
          <year>2000</year>
<volume>30</volume>
<fpage>725</fpage>
<lpage>732</lpage>
<pub-id pub-id-type="pmid">11100486</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lanjewar</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Shetty</surname>
<given-names>CR</given-names>
</name>
</person-group>
<article-title>Profile of central nervous system pathology in patients with AIDS: an autopsy study from India</article-title>
<source/>AIDS
          <year>1998</year>
<volume>12</volume>
<issue>3</issue>
<fpage>309</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="pmid">9517994</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Safadi</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Berezin</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Farhat</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>ES</given-names>
</name>
</person-group>
<article-title>Clinical presentation and follow up of children with congenital toxoplasmosis in Brazil</article-title>
<source/>Braz J Infect Dis
          <year>2003</year>
<volume>7</volume>
<issue>5</issue>
<fpage>325</fpage>
<lpage>331</lpage>
<pub-id pub-id-type="pmid">14552742</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reyes</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Zalewska</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Besarab</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Intracranial calcification in adults with chronic lead exposure</article-title>
<source/>AJR Am J Roentgenol
          <year>1986</year>
<volume>146</volume>
<issue>2</issue>
<fpage>267</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="pmid">3484574</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tonge</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Burry</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Saal</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Cerebellar calcification: a possible marker of lead poisoning</article-title>
<source/>Pathology
          <year>1977</year>
<volume>9</volume>
<issue>4</issue>
<fpage>289</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="pmid">201908</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Golla</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dey</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Mahankali</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Seelam</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Image of the month: intracranial calcifications due to chronic lead exposure</article-title>
<source/>Clin Med (Lond)
          <year>2016</year>
<volume>16</volume>
<issue>5</issue>
<fpage>494</fpage>
<pub-id pub-id-type="pmid">27697819</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teo</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Goh</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Ahuja</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>WS</given-names>
</name>
</person-group>
<article-title>Intracranial vascular calcifications, glioblastoma multiforme, and lead poisoning</article-title>
<source/>AJNR Am J Neuroradiol
          <year>1997</year>
<volume>18</volume>
<issue>3</issue>
<fpage>576</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="pmid">9090426</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Illum</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Calcification of the basal ganglia following carbon monoxide poisoning</article-title>
<source/>Neuroradiology
          <year>1980</year>
<volume>19</volume>
<fpage>213</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="pmid">7383343</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Souirti</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Lahlou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ouali</surname>
<given-names>OE</given-names>
</name>
<name>
<surname>Chtaou</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Aarab</surname>
<given-names>C</given-names>
</name>
<name>
<surname>El Ghazouani</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuropsychiatric systemic lupus erythematosus</article-title>
<source/>Open J Rheumatol Autoimmune Dis
          <year>2013</year>
<volume>3</volume>
<fpage>86</fpage>
<lpage>91</lpage>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jospeh</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Scolding</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>Neurolupus</article-title>
<source/>Pract Neurol
          <year>2010</year>
<volume>10</volume>
<fpage>4</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">20130291</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raymond</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Zariah</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Samad</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>NC</given-names>
</name>
</person-group>
<article-title>Brain calcification inpatients with cerebral lupus</article-title>
<source/>Lupus
          <year>1996</year>
<volume>5</volume>
<fpage>123</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="pmid">8743125</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canas</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Tobon</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>Multiple brain calcifications in a patient with systemic lupus erythematosus</article-title>
<source/>Clin Rheumatol
          <year>2008</year>
<volume>27</volume>
<fpage>S63</fpage>
<lpage>S65</lpage>
<pub-id pub-id-type="pmid">18506566</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaliterna</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Radic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Radic</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kovacic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Fabijanic</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Massive cerebral calcifications (Fahr’s disease) in a patient with systemic lupus erythematosus and no major neuropsychological abnormality</article-title>
<source/>Isr Med Assoc J
          <year>2013</year>
<volume>15</volume>
<issue>10</issue>
<fpage>654</fpage>
<lpage>655</lpage>
<pub-id pub-id-type="pmid">24266097</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Leung</surname>
<given-names>CYW</given-names>
</name>
<name>
<surname>Leong</surname>
<given-names>HS</given-names>
</name>
</person-group>
<article-title>Bilateral striatopallidodentate calcinosis associated with systemic lupus erythematosus: case report and review of literature</article-title>
<source/>J Neurol Sci
          <year>2015</year>
<volume>358</volume>
<issue>1–2</issue>
<fpage>518</fpage>
<lpage>519</lpage>
<pub-id pub-id-type="pmid">26440422</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mantovani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Romoli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutational analysis of GNAS1 in patients with pseudohypoparathyroidism: identification of two novel mutations</article-title>
<source/>J Clin Endocrinol Metab
          <year>2000</year>
<volume>85</volume>
<issue>11</issue>
<fpage>4243</fpage>
<lpage>4248</lpage>
<pub-id pub-id-type="pmid">11095461</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karikkineth</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Scheibye-Knudsen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fivenson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Croteau</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Bohr</surname>
<given-names>VA</given-names>
</name>
</person-group>
<article-title>Cockayne syndrome: clinical features, model systems and pathways</article-title>
<source/>Ageing Res Rev
          <year>2017</year>
<volume>33</volume>
<fpage>3</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="pmid">27507608</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laugel</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Cockayne syndrome: the expanding clinical and mutational spectrum</article-title>
<source/>Mech Ageing Dev
          <year>2013</year>
<volume>134</volume>
<issue>5–6</issue>
<fpage>161</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="pmid">23428416</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koob</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Laugel</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Durand</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fothergill</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dalloz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sauvanaud</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dollfus</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Namer</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Dietemann</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Neuroimaging in Cockayne syndrome</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2010</year>
<volume>31</volume>
<issue>9</issue>
<fpage>1623</fpage>
<lpage>1630</lpage>
<pub-id pub-id-type="pmid">20522568</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deepak Amalnath</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mailankody</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Teaching NeuroImages: Cockayne syndrome with extensive intracranial calcification</article-title>
<source/>Neurology
          <year>2015</year>
<volume>84</volume>
<fpage>e137</fpage>
<pub-id pub-id-type="pmid">25941205</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goutières</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Aicardi-Goutières syndrome</article-title>
<source/>Brain and Development
          <year>2005</year>
<volume>27</volume>
<issue>3</issue>
<fpage>201</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="pmid">15737701</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crow</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Hayward</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Parmar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Robins</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Leitch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>van Bokhoven</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Hamel</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Corry</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Cowan</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Frints</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Klepper</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Livingston</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Massey</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Meritet</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Michaud</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Ponsot</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Voit</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lebon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bonthron</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Lindahl</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus</article-title>
<source/>Nat Genet
          <year>2006</year>
<volume>38</volume>
<issue>8</issue>
<fpage>917</fpage>
<lpage>920</lpage>
<pub-id pub-id-type="pmid">16845398</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rice</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Patrick</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Parmar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Aeby</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aicardi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Artuch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Montalto</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Bacino</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Barroso</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Baxter</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Benko</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bertini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Biancheri</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Blair</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Blau</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bonthron</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Briggs</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brueton</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Burke</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Christen</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Corry</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Cowan</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>H</given-names>
</name>
<name>
<surname>D’Arrigo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>J</given-names>
</name>
<name>
<surname>de Laet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>de Praeter</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Déry</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ferrie</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Flintoff</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Frints</surname>
<given-names>SGM</given-names>
</name>
<name>
<surname>Garcia-Cazorla</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gener</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Goizet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Goutières</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Guët</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hamel</surname>
<given-names>BCJ</given-names>
</name>
<name>
<surname>Hayward</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Heiberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hennekam</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Husson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Jayatunga</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Kant</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>A</given-names>
</name>
<name>
<surname>King</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Kingston</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Klepper</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van der Knaap</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Kornberg</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Kotzot</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kratzer</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lacombe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lagae</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Landrieu</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Lanzi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Leitch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Livingston</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Lourenco</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Lyall</surname>
<given-names>EGH</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Lyons</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Marom</surname>
<given-names>D</given-names>
</name>
<name>
<surname>McClure</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>McWilliam</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Melancon</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Mewasingh</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Moutard</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Nischal</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Østergaard</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Prendiville</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Roland</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rosser</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Rostasy</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Roubertie</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sanchis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schiffmann</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Scholl-Bürgi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Seal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shalev</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Corcoles</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Soler</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Spiegel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>JBP</given-names>
</name>
<name>
<surname>Tacke</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Till</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tolmie</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Tomlin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vagnarelli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Valente</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>van Coster</surname>
<given-names>RNA</given-names>
</name>
<name>
<surname>van der Aa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Vanderver</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vles</surname>
<given-names>JSH</given-names>
</name>
<name>
<surname>Voit</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wassmer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Weschke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Whiteford</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>MAA</given-names>
</name>
<name>
<surname>Zankl</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zuberi</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Orcesi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fazzi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lebon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Crow</surname>
<given-names>YJ</given-names>
</name>
</person-group>
<article-title>Clinical and molecular phenotype of Aicardi-Goutieres syndrome</article-title>
<source/>Am J Hum Genet
          <year>2007</year>
<volume>81</volume>
<issue>4</issue>
<fpage>713</fpage>
<lpage>725</lpage>
<pub-id pub-id-type="pmid">17846997</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uggetti</surname>
<given-names>C</given-names>
</name>
<name>
<surname>La Piana</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Orcesi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Egitto</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Crow</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Fazzi</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Aicardi-Goutieres syndrome: neuroradiologic findings and follow-up</article-title>
<source/>AJNR Am J Neuroradiol
          <year>2009</year>
<volume>30</volume>
<issue>10</issue>
<fpage>1971</fpage>
<lpage>1976</lpage>
<pub-id pub-id-type="pmid">19628626</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majamaa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Moilanen</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Uimonen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Remes</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Salmela</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Kärppä</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Majamaa-Voltti</surname>
<given-names>KAM</given-names>
</name>
<name>
<surname>Rusanen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sorri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Peuhkurinen</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Hassinen</surname>
<given-names>IE</given-names>
</name>
</person-group>
<article-title>Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population</article-title>
<source/>Am J Hum Genet
          <year>1998</year>
<volume>63</volume>
<issue>2</issue>
<fpage>447</fpage>
<lpage>454</lpage>
<pub-id pub-id-type="pmid">9683591</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lorenzoni</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Werneck</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Kay</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Silvado</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Scola</surname>
<given-names>RH</given-names>
</name>
</person-group>
<article-title>When should MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) be the diagnosis?</article-title>
<source/>Arq Neuropsiquiatr
          <year>2015</year>
<volume>73</volume>
<issue>11</issue>
<fpage>959</fpage>
<lpage>967</lpage>
<pub-id pub-id-type="pmid">26517220</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ozawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nagahama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fukuyama</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Akiguchi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kaji</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A novel point mutation in the mitochondrial tRNA(Ser(UCN)) gene detected in a family with MERRF/MELAS overlap syndrome</article-title>
<source/>Biochem Biophys Res Commun
          <year>1995</year>
<volume>214</volume>
<issue>1</issue>
<fpage>86</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">7669057</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Black</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Perveen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bonshek</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cahill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Clayton-Smith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>McLeod</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Coats’ disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis</article-title>
<source/>Hum Mol Genet
          <year>1999</year>
<volume>8</volume>
<issue>11</issue>
<fpage>2031</fpage>
<lpage>2035</lpage>
<pub-id pub-id-type="pmid">10484772</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goutières</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dollfus</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Becquet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dufier</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Extensive brain calcification in two children with bilateral Coats’ disease</article-title>
<source/>Neuropediatrics
          <year>1999</year>
<volume>30</volume>
<issue>1</issue>
<fpage>19</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">10222456</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Singhal</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Groden</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Toro</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Idiopathic basal ganglia calcifications: an atypical presentation of PKAN</article-title>
<source/>Pediatr Neurol
          <year>2013</year>
<volume>49</volume>
<issue>5</issue>
<fpage>351</fpage>
<lpage>354</lpage>
<pub-id pub-id-type="pmid">23968566</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fasano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shahidi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Rohani</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Basal ganglia calcification in a case of PKAN</article-title>
<source/>Parkinsonism Relat Disord
          <year>2017</year>
<volume>36</volume>
<fpage>98</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">28024710</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Goethem</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Livingston</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Oojageer</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>GI</given-names>
</name>
<name>
<surname>Crow</surname>
<given-names>YJ</given-names>
</name>
</person-group>
<article-title>Basal ganglia calcification in a patient with beta-propeller protein-associated neurodegeneration</article-title>
<source/>Pediatr Neurol
          <year>2014</year>
<volume>51</volume>
<issue>6</issue>
<fpage>843</fpage>
<lpage>845</lpage>
<pub-id pub-id-type="pmid">25301227</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoganathan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arunachal</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sudhakar</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Rajaraman</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Danda</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Beta propellar protein-associated neurodegeneration: a rare cause of infantile autistic regression and intracranial calcification</article-title>
<source/>Neuropediatrics
          <year>2016</year>
<volume>47</volume>
<issue>2</issue>
<fpage>123</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="pmid">26859818</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>ZH</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>CY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel RAB39B gene mutation in X-linked juvenile parkinsonism with basal ganglia calcification</article-title>
<source/>Mov Disord
          <year>2016</year>
<volume>12</volume>
<fpage>1905</fpage>
<lpage>1909</lpage>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tai</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Batla</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Fahr’s disease: current perspectives</article-title>
<source/>Orphan Drugs: Research and Reviews
          <year>2015</year>
<volume>5</volume>
<fpage>43</fpage>
<lpage>49</lpage>
</element-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loeb</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Functional improvement in a patient with cerebral calcinosis using a bisphosphonate</article-title>
<source/>Mov Disord
          <year>1998</year>
<volume>13</volume>
<issue>2</issue>
<fpage>345</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="pmid">9539353</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>Primary brain calcification in patients undergoing treatment with the biphosphanate alendronate</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>22961</fpage>
<pub-id pub-id-type="pmid">26976513</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>